Stockscreener 앱 받기
2.07
0.98%
0.02
시간 외 거래:
2.10
0.03
+1.45%
전일 마감가:
$2.05
열려 있는:
$2.1
하루 거래량:
2.55M
Relative Volume:
1.79
시가총액:
$192.52M
수익:
$34.48M
순이익/손실:
$-102.07M
주가수익비율:
-1.4178
EPS:
-1.46
순현금흐름:
$-104.90M
1주 성능:
+21.76%
1개월 성능:
+54.48%
6개월 성능:
+36.18%
1년 성능:
-9.80%
1일 변동 폭
$2.05
$2.34
1주일 범위
$1.605
$2.34
52주 변동 폭
$0.66
$2.9995
Caribou Biosciences Inc Stock (CRBU) Company Profile
명칭
Caribou Biosciences Inc
전화
510-982-6030
주소
2929 7TH STREET, SUITE 105, BERKELEY
CRBU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
2.07 | 158.11M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-11-08 | 개시 | Cantor Fitzgerald | Neutral |
| 2023-10-31 | 개시 | Evercore ISI | Outperform |
| 2023-07-11 | 개시 | Truist | Buy |
| 2022-02-18 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-30 | 개시 | H.C. Wainwright | Buy |
| 2021-11-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-08-17 | 개시 | BofA Securities | Buy |
| 2021-08-17 | 개시 | Citigroup | Neutral |
| 2021-08-17 | 개시 | SVB Leerink | Outperform |
모두보기
Caribou Biosciences Inc 주식(CRBU)의 최신 뉴스
Caribou Biosciences Inc. Stock Analysis and ForecastFree Smart Trading Workshop - PrintWeekIndia
What drives Caribou Biosciences Inc. stock priceAccelerated financial growth - PrintWeekIndia
What analysts say about Caribou Biosciences Inc. stockRapid return acceleration - jammulinksnews.com
Why Caribou Biosciences Inc. stock is on top investor watchlistsFast Gains With Reduced Risk - Newser
Citi reiterates Buy rating on Caribou Biosciences stock ahead of key data - Investing.com Australia
Caribou Biosciences: Key Data Updates Coming, But I'm Concerned About Near-Term Volatility - Seeking Alpha
Investors Can Still File Late Claims in Caribou Bioscience Settlement — Here’s How to Get Your Share - TradingView
Rachel Haurwitz - Forbes
Why Caribou Biosciences Inc. stock attracts strong analyst attentionRisk Adjusted Stock Signals - Newser
How Caribou Biosciences Inc. stock performs during market volatilityTriple Return With Stability - Newser
What makes Caribou Biosciences Inc. stock price move sharplyVerified Return Tips - Newser
Caribou Biosciences(CRBU) soars 9.38% on FDA clearance, institutional interest - AInvest
Caribou Biosciences shares rise 1.88% in premarket after being listed as one of four stocks poised to ride the 2025 biotech growth wave. - AInvest
Biotech Sector Shows Promising Growth with Key Players Leading Innovation - citybuzz -
Caribou Biosciences (CRBU) Is Paying a $3.9M Settlement to Investors — Here’s How to Get Your Share - TradingView
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. LawsuitCRBU - ACCESS Newswire
Caribou Biosciences Regains Nasdaq Compliance, Maintains Minimum Closing Bid Price - AInvest
Caribou Biosciences regains Nasdaq compliance with $1 minimum bid By Investing.com - Investing.com Canada
Discovering RF Industries And 2 Other Promising Penny Stocks - simplywall.st
Caribou Biosciences Announces Director Elections and Auditor Confirmation - AInvest
Caribou Biosciences Confirms Director Elections and Auditor - TipRanks
Analysts Offer Predictions for CRBU FY2026 Earnings - Defense World
Caribou Biosciences (NASDAQ:CRBU) versus AlloVir (NASDAQ:ALVR) Critical Contrast - Defense World
Public Employees Retirement System of Ohio Takes $222,000 Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Nuveen Asset Management LLC Acquires 63,096 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionCRBU - ACCESS Newswire
Millennium Management LLC Has $1.37 Million Holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Ameriprise Financial Inc. Purchases New Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
CRISPR Market Research and Competitive Landscape Report 2025Global Forecast to 2030: Rising Adoption in Research and Therapy Drives Growth with Thermo Fisher Scientific and Merck Leading - GlobeNewswire
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Acquired by Two Sigma Investments LP - Defense World
Bank of America Corp DE Sells 2,800,953 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Caribou Biosciences, Inc. (NASDAQ:CRBU) Holdings Lowered by Jane Street Group LLC - Defense World
Northern Trust Corp Boosts Stake in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference - The Manila Times
Caribou Biosciences CEO Fireside Chat: Latest CRISPR Innovations at Jefferies Conference - Stock Titan
Caribou Biosciences’ SWOT analysis: biotech stock faces pivotal moment By Investing.com - Investing.com South Africa
Caribou Biosciences’ SWOT analysis: biotech stock faces pivotal moment - Investing.com
Layoff Tracker: Eikon Cuts Workforce by 15%, Citing ‘External Forces’ - BioSpace
3 Promising Penny Stocks With Market Caps Under $200M - simplywall.st
Caribou Biosciences Inc (CRBU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.17%
자본화:
|
볼륨(24시간):